Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Journal of Alzheimer'S Disease : JAD
|
April 2, 2014
Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro
Yan Zhao, Hailin Zhao, Niyati Lobo, et al.
Molecular and Cellular Biology
|
August 29, 2012
Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein
Callum Parr, Raffaela Carzaniga, Steve M Gentleman, et al.
Journal of Neuroinflammation
|
September 4, 2016
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide
Miriam Ries, Rodrigo Loiola, Urvi N Shah, et al.
Journal of Molecular Neuroscience : MN
|
May 19, 2015
Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease
Michael J Hurley, Pascal F Durrenberger, Steve M Gentleman, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 28, 2021
Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease
Lindsey Sinclair, Jake Brenton, Alan King Lun Liu, et al.
Acta Neuropathologica
|
January 31, 2015
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease
Alan King Lun Liu, Raymond Chuen-Chung Chang, Ronald K B Pearce, et al.
Acta Neuropathologica Communications
|
February 18, 2014
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease
Peixuan Pey, Ronald K B Pearce, Michail E Kalaitzakis, et al.
Journal of Parkinson'S Disease
|
August 2, 2021
Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia
Bension S Tilley, Shivani R Patel, Marc H Goldfinger, et al.
Acta Neuropathologica Communications
|
December 2, 2015
Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders
Athanasios Alexandris, Alan King Lun Liu, Raymond Chuen-Chung Chang, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 20, 2020
Iron and inflammation: in vivo and post-mortem studies in Parkinson's disease
Antonio Martin-Bastida, Bension Shlomo Tilley, Sukhi Bansal, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Journal of Alzheimer'S Disease : JAD
|
April 2, 2014
Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro
Yan Zhao, Hailin Zhao, Niyati Lobo, et al.
Molecular and Cellular Biology
|
August 29, 2012
Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein
Callum Parr, Raffaela Carzaniga, Steve M Gentleman, et al.
Journal of Neuroinflammation
|
September 4, 2016
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide
Miriam Ries, Rodrigo Loiola, Urvi N Shah, et al.
Journal of Molecular Neuroscience : MN
|
May 19, 2015
Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease
Michael J Hurley, Pascal F Durrenberger, Steve M Gentleman, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 28, 2021
Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease
Lindsey Sinclair, Jake Brenton, Alan King Lun Liu, et al.
Acta Neuropathologica
|
January 31, 2015
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease
Alan King Lun Liu, Raymond Chuen-Chung Chang, Ronald K B Pearce, et al.
Acta Neuropathologica Communications
|
February 18, 2014
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease
Peixuan Pey, Ronald K B Pearce, Michail E Kalaitzakis, et al.
Journal of Parkinson'S Disease
|
August 2, 2021
Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia
Bension S Tilley, Shivani R Patel, Marc H Goldfinger, et al.
Acta Neuropathologica Communications
|
December 2, 2015
Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders
Athanasios Alexandris, Alan King Lun Liu, Raymond Chuen-Chung Chang, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 20, 2020
Iron and inflammation: in vivo and post-mortem studies in Parkinson's disease
Antonio Martin-Bastida, Bension Shlomo Tilley, Sukhi Bansal, et al.
Page
of 4